Loading…

One week eradication regimen for Helicobacter pylori

Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amo...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1991-11, Vol.338 (8777), p.1249-1252
Main Authors: Logan, R.P.H., Gummett, P.A., Misiewicz, J.J., Karim, Q.N., Walker, M.M., Baron, J.H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3
cites cdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3
container_end_page 1252
container_issue 8777
container_start_page 1249
container_title The Lancet (British edition)
container_volume 338
creator Logan, R.P.H.
Gummett, P.A.
Misiewicz, J.J.
Karim, Q.N.
Walker, M.M.
Baron, J.H.
description Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.
doi_str_mv 10.1016/0140-6736(91)92111-E
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72458849</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>014067369192111E</els_id><sourcerecordid>2210389178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</originalsourceid><addsrcrecordid>eNp9kE1rFEEQhhtR4ib6DxQGFdHDaFdPf14ECasRArkoeGv6o0Y6zk6v3bNK_r292SWCoFRBHeqp4uUh5AnQN0BBvqXAaS_VIF8ZeG0YAPTre2QFXPFecPX1PlndIQ_Jaa3XlFIuqTghJyA1k2JYEX41Y_cL8XuHxcUU3JLy3BX8ljY4d2Mu3QVOKWTvwoKl295MuaRH5MHopoqPj_OMfPmw_nx-0V9effx0_v6yD2KApR-jMZ5pDQJhiNELpTVjXBnpkXomQlQBpPTKgKBCMsMci-DG1j6C98MZeXn4uy35xw7rYjepBpwmN2PeVasYF1pz08Dnf4HXeVfmls0yBnTQBpRu1LN_UWC04VJzaBA_QKHkWguOdlvSxpUbC9Tuvdu9VLuXag3YW-923c6eHn_v_Abjn6OD6LZ_cdy7Gtw0FjeHVO8wQWUr1rB3Bwyb1p8Ji60h4RwwpoJhsTGn_-f4DfD3m4s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198946841</pqid></control><display><type>article</type><title>One week eradication regimen for Helicobacter pylori</title><source>EBSCOhost Business Source Ultimate</source><creator>Logan, R.P.H. ; Gummett, P.A. ; Misiewicz, J.J. ; Karim, Q.N. ; Walker, M.M. ; Baron, J.H.</creator><creatorcontrib>Logan, R.P.H. ; Gummett, P.A. ; Misiewicz, J.J. ; Karim, Q.N. ; Walker, M.M. ; Baron, J.H.</creatorcontrib><description>Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(91)92111-E</identifier><identifier>PMID: 1682653</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Algorithms ; Amoxicillin ; Amoxicillin - administration &amp; dosage ; Anti-Ulcer Agents - administration &amp; dosage ; Biological and medical sciences ; Digestive system ; Drug Administration Schedule ; Drug Combinations ; Drug Resistance, Microbial ; Drugs ; Dyspepsia ; Eradication ; Female ; Follow-Up Studies ; Gastritis ; Helicobacter Infections - diagnosis ; Helicobacter Infections - drug therapy ; Helicobacter pylori ; Helicobacter pylori - drug effects ; Helicobacter pylori - isolation &amp; purification ; Humans ; Male ; Medical disorders ; Medical research ; Medical sciences ; Metronidazole ; Metronidazole - administration &amp; dosage ; Middle Aged ; Organometallic Compounds - administration &amp; dosage ; Patient Compliance ; Patients ; Pharmacology. Drug treatments ; Pyloric Antrum - microbiology ; Time Factors ; Ulcers</subject><ispartof>The Lancet (British edition), 1991-11, Vol.338 (8777), p.1249-1252</ispartof><rights>1991</rights><rights>1992 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Nov 16, 1991</rights><rights>Copyright Elsevier Limited Nov 16, 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</citedby><cites>FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5060602$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1682653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Logan, R.P.H.</creatorcontrib><creatorcontrib>Gummett, P.A.</creatorcontrib><creatorcontrib>Misiewicz, J.J.</creatorcontrib><creatorcontrib>Karim, Q.N.</creatorcontrib><creatorcontrib>Walker, M.M.</creatorcontrib><creatorcontrib>Baron, J.H.</creatorcontrib><title>One week eradication regimen for Helicobacter pylori</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Algorithms</subject><subject>Amoxicillin</subject><subject>Amoxicillin - administration &amp; dosage</subject><subject>Anti-Ulcer Agents - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Digestive system</subject><subject>Drug Administration Schedule</subject><subject>Drug Combinations</subject><subject>Drug Resistance, Microbial</subject><subject>Drugs</subject><subject>Dyspepsia</subject><subject>Eradication</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastritis</subject><subject>Helicobacter Infections - diagnosis</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - drug effects</subject><subject>Helicobacter pylori - isolation &amp; purification</subject><subject>Humans</subject><subject>Male</subject><subject>Medical disorders</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Metronidazole</subject><subject>Metronidazole - administration &amp; dosage</subject><subject>Middle Aged</subject><subject>Organometallic Compounds - administration &amp; dosage</subject><subject>Patient Compliance</subject><subject>Patients</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyloric Antrum - microbiology</subject><subject>Time Factors</subject><subject>Ulcers</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rFEEQhhtR4ib6DxQGFdHDaFdPf14ECasRArkoeGv6o0Y6zk6v3bNK_r292SWCoFRBHeqp4uUh5AnQN0BBvqXAaS_VIF8ZeG0YAPTre2QFXPFecPX1PlndIQ_Jaa3XlFIuqTghJyA1k2JYEX41Y_cL8XuHxcUU3JLy3BX8ljY4d2Mu3QVOKWTvwoKl295MuaRH5MHopoqPj_OMfPmw_nx-0V9effx0_v6yD2KApR-jMZ5pDQJhiNELpTVjXBnpkXomQlQBpPTKgKBCMsMci-DG1j6C98MZeXn4uy35xw7rYjepBpwmN2PeVasYF1pz08Dnf4HXeVfmls0yBnTQBpRu1LN_UWC04VJzaBA_QKHkWguOdlvSxpUbC9Tuvdu9VLuXag3YW-923c6eHn_v_Abjn6OD6LZ_cdy7Gtw0FjeHVO8wQWUr1rB3Bwyb1p8Ji60h4RwwpoJhsTGn_-f4DfD3m4s</recordid><startdate>19911116</startdate><enddate>19911116</enddate><creator>Logan, R.P.H.</creator><creator>Gummett, P.A.</creator><creator>Misiewicz, J.J.</creator><creator>Karim, Q.N.</creator><creator>Walker, M.M.</creator><creator>Baron, J.H.</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>ASE</scope><scope>C1K</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>KB~</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>19911116</creationdate><title>One week eradication regimen for Helicobacter pylori</title><author>Logan, R.P.H. ; Gummett, P.A. ; Misiewicz, J.J. ; Karim, Q.N. ; Walker, M.M. ; Baron, J.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Algorithms</topic><topic>Amoxicillin</topic><topic>Amoxicillin - administration &amp; dosage</topic><topic>Anti-Ulcer Agents - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Digestive system</topic><topic>Drug Administration Schedule</topic><topic>Drug Combinations</topic><topic>Drug Resistance, Microbial</topic><topic>Drugs</topic><topic>Dyspepsia</topic><topic>Eradication</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastritis</topic><topic>Helicobacter Infections - diagnosis</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - drug effects</topic><topic>Helicobacter pylori - isolation &amp; purification</topic><topic>Humans</topic><topic>Male</topic><topic>Medical disorders</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Metronidazole</topic><topic>Metronidazole - administration &amp; dosage</topic><topic>Middle Aged</topic><topic>Organometallic Compounds - administration &amp; dosage</topic><topic>Patient Compliance</topic><topic>Patients</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyloric Antrum - microbiology</topic><topic>Time Factors</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Logan, R.P.H.</creatorcontrib><creatorcontrib>Gummett, P.A.</creatorcontrib><creatorcontrib>Misiewicz, J.J.</creatorcontrib><creatorcontrib>Karim, Q.N.</creatorcontrib><creatorcontrib>Walker, M.M.</creatorcontrib><creatorcontrib>Baron, J.H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Newsstand Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Logan, R.P.H.</au><au>Gummett, P.A.</au><au>Misiewicz, J.J.</au><au>Karim, Q.N.</au><au>Walker, M.M.</au><au>Baron, J.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One week eradication regimen for Helicobacter pylori</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1991-11-16</date><risdate>1991</risdate><volume>338</volume><issue>8777</issue><spage>1249</spage><epage>1252</epage><pages>1249-1252</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori,were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9·3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>1682653</pmid><doi>10.1016/0140-6736(91)92111-E</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1991-11, Vol.338 (8777), p.1249-1252
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_72458849
source EBSCOhost Business Source Ultimate
subjects Adolescent
Adult
Aged
Aged, 80 and over
Algorithms
Amoxicillin
Amoxicillin - administration & dosage
Anti-Ulcer Agents - administration & dosage
Biological and medical sciences
Digestive system
Drug Administration Schedule
Drug Combinations
Drug Resistance, Microbial
Drugs
Dyspepsia
Eradication
Female
Follow-Up Studies
Gastritis
Helicobacter Infections - diagnosis
Helicobacter Infections - drug therapy
Helicobacter pylori
Helicobacter pylori - drug effects
Helicobacter pylori - isolation & purification
Humans
Male
Medical disorders
Medical research
Medical sciences
Metronidazole
Metronidazole - administration & dosage
Middle Aged
Organometallic Compounds - administration & dosage
Patient Compliance
Patients
Pharmacology. Drug treatments
Pyloric Antrum - microbiology
Time Factors
Ulcers
title One week eradication regimen for Helicobacter pylori
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A45%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One%20week%20eradication%20regimen%20for%20Helicobacter%20pylori&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Logan,%20R.P.H.&rft.date=1991-11-16&rft.volume=338&rft.issue=8777&rft.spage=1249&rft.epage=1252&rft.pages=1249-1252&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(91)92111-E&rft_dat=%3Cproquest_cross%3E2210389178%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c531t-fd99b28815e13ddb5788224796be0b25cd7c166b7915056292a2d1af1afbd1bb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=198946841&rft_id=info:pmid/1682653&rfr_iscdi=true